Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Thomas Hundsberger, David A. Reardon & Patrick Y. Wen. (2017) Angiogenesis inhibitors in tackling recurrent glioblastoma. Expert Review of Anticancer Therapy 17:6, pages 507-515.
Read now
Read now
Sarah E. Fenton, Jeffrey A. Sosman & Sunandana Chandra. (2017) Emerging growth factor receptor antagonists for the treatment of advanced melanoma. Expert Opinion on Emerging Drugs 22:2, pages 165-174.
Read now
Read now
Antonella Sistigu, Gwenola Manic, Florine Obrist & Ilio Vitale. (2016) Trial watch – inhibiting PARP enzymes for anticancer therapy. Molecular & Cellular Oncology 3:2.
Read now
Read now
Travis E Grotz, James W Jakub, Aaron S Mansfield, Rachel Goldenstein, Elizabeth Ann L Enninga, Wendy K Nevala, Alexey A Leontovich & Svetomir N Markovic. (2015) Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma. OncoImmunology 4:8.
Read now
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Read now
Erika Vacchelli, Jonathan Pol, Norma Bloy, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jérôme Galon, Aurélien Marabelle, Holbrook Kohrt, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. OncoImmunology 4:1.
Read now
Read now
Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology 3:9.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:1.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Read now
Articles from other publishers (23)
Saba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol, Xiaoyu Li, Jingjing Li, Charles H. Yoon, Michael P. Manos, David A. Barbie & F. Stephen Hodi. (2023) EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade. Cancer Immunology Research 11:11, pages 1493-1507.
Crossref
Crossref
Joleen M. Hubbard, Enikő R. Tőke, Roberto Moretto, Rondell P. Graham, Hagop Youssoufian, Orsolya Lőrincz, Levente Molnár, Zsolt Csiszovszki, Jessica L. Mitchell, Jaclynn Wessling, József Tóth & Chiara Cremolini. (2022) Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study. Clinical Cancer Research 28:13, pages 2818-2829.
Crossref
Crossref
Chirayu R. Chokshi, Benjamin A. Brakel, Nazanin Tatari, Neil Savage, Sabra K. Salim, Chitra Venugopal & Sheila K. Singh. (2021) Advances in Immunotherapy for Adult Glioblastoma. Cancers 13:14, pages 3400.
Crossref
Crossref
Narendra Kumar, Ashutosh Rai, Pinaki Dutta, Prakamya Gupta, Paramjeet Singh, KanchanK Mukherjee & Sivashanmugam Dhandapani. (2021) Noncontiguous Radiation-Induced Brain Necrosis (RIBN) in a Patient with Aggressive Pituitary Adenoma and the Utility of Bevacizumab. Neurology India 69:4, pages 1055.
Crossref
Crossref
Ze-Long Liu, Jing-Hua Liu, Daniel Staiculescu & Jiang Chen. (2021) Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment. Therapeutic Advances in Medical Oncology 13, pages 175883592110180.
Crossref
Crossref
Licia Rivoltini, Agata Cova & Paola Squarcina. 2021. New Therapies in Advanced Cutaneous Malignancies. New Therapies in Advanced Cutaneous Malignancies
99
128
.
Svetomir N. Markovic, Vera J. Suman, Asad Javed, Joel M. Reid, Darci J. Wall, Lori A. Erickson, Marc Ernstoff & Daniel M. Anderson. (2020) Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma. American Journal of Clinical Oncology 43:2, pages 115-121.
Crossref
Crossref
Elaine Reguera-Nuñez, Shan Man, Ping Xu, Frank Hilberg & Robert S. Kerbel. (2019) Variable impact of three different antiangiogenic drugs alone or in combination with chemotherapy on multiple bone marrow-derived cell populations involved in angiogenesis and immunity. Angiogenesis 22:4, pages 535-546.
Crossref
Crossref
Emilio Francesco Giunta, Giuseppe Argenziano, Gabriella Brancaccio, Erika Martinelli, Fortunato Ciardiello & Teresa Troiani. (2019) Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment. Current Cancer Therapy Reviews 15:2, pages 110-119.
Crossref
Crossref
Huemer, Lang, Westphal, Gampenrieder, Hutarew, Weiss, Hackl, Lamprecht, Rinnerthaler & Greil. (2019) Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade. Journal of Clinical Medicine 8:7, pages 1014.
Crossref
Crossref
Sarah E. Fenton, Jeffrey A. Sosman & Sunandana Chandra. 2019. Cutaneous Melanoma [Working Title]. Cutaneous Melanoma [Working Title].
Yiyi Yan, Anagha Bangalore Kumar, Heidi Finnes, Svetomir N. Markovic, Sean Park, Roxana S. Dronca & Haidong Dong. (2018) Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy. Frontiers in Immunology 9.
Crossref
Crossref
K.A. Riccione, P. Gedeon, L. Sanchez-Perez & J.H. Sampson. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
261
300
.
Chloé Rancoule, Alexis Vallard, Sophie Espenel, Jean-Baptiste Guy, Yaoxiong Xia, Anis El Meddeb Hamrouni, Claire Rodriguez-Lafrasse, Cyrus Chargari, Eric Deutsch & Nicolas Magné. (2016) Immunotherapy in head and neck cancer: Harnessing profit on a system disruption. Oral Oncology 62, pages 153-162.
Crossref
Crossref
EC Martino, G Misso, P Pastina, S Costantini, F Vanni, C Gandolfo, C Botta, F Capone, A Lombardi, L Pirtoli, P Tassone, C Ulivieri, P Tagliaferri, MG Cusi, M Caraglia & P Correale. (2016) Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients. Cell Death Discovery 2:1.
Crossref
Crossref
Danielle N. Renner, Courtney S. Malo, Fang Jin, Ian F. Parney, Kevin D. Pavelko & Aaron J. Johnson. (2015) Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model. Neurotherapeutics 13:1, pages 226-236.
Crossref
Crossref
Lysanne Lievense, Joachim Aerts & Joost Hegmans. 2016. Lung Cancer and Personalized Medicine. Lung Cancer and Personalized Medicine
59
90
.
Claudia Sorrentino, Lucio Miele, Amalia Porta, Aldo Pinto & Silvana Morello. (2015) Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model. Oncotarget 6:29, pages 27478-27489.
Crossref
Crossref
Matthias Preusser, Michael Lim, David A. Hafler, David A. Reardon & John H. Sampson. (2015) Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nature Reviews Neurology 11:9, pages 504-514.
Crossref
Crossref
Qiao Li, Mark E.P. Prince & Jeffrey S. Moyer. (2015) Immunotherapy for head and neck squamous cell carcinoma. Oral Oncology 51:4, pages 299-304.
Crossref
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref
Vincenzo Formica, Jessica Luccchetti, David Cunningham, Elizabeth C. Smyth, Patrizia Ferroni, Antonella Nardecchia, Manfredi Tesauro, Vittore Cereda, Fiorella Guadagni & Mario Roselli. (2014) Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients. Medical Oncology 31:9.
Crossref
Crossref
Elizabeth Ann L. Enninga, Shernan G. Holtan, Douglas J. Creedon, Roxana S. Dronca, Wendy K. Nevala, Simona Ognjanovic & Svetomir N. Markovic. (2014) Immunomodulatory Effects of Sex Hormones: Requirements for Pregnancy and Relevance in Melanoma. Mayo Clinic Proceedings 89:4, pages 520-535.
Crossref
Crossref